Condition
Focal Laser Ablation
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Mrguided Focal Laser Ablation
Research Leaders
7 sponsors active, led by Elesta S.R.L.
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Mrguided Focal Laser Ablation1
- Echolaser X4 System1
Active Sponsors
- Elesta S.R.L.1
- Radboud University Medical Center1
- The Netherlands Cancer Institute1
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
- Amsterdam UMC, location VUmc1
Top Investigators
Urologist
Radboud University Nijmegen Medical Center
Related Conditions
- Prostate Cancer2
- Mri1
- Transperineal Laser Ablation1